Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Before Lipitor Switch Final Exam, Pfizer Survey Studies Self-Care

This article was originally published in The Tan Sheet

Executive Summary

Consumers want more self-care opportunities, but consumer self-confidence alone is not enough to switch a currently Rx drug indicated for high cholesterol. Pfizer continues analyzing data from an actual use study to determine whether it will sponsor a switch NDA for 10mg Lipitor.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS107655

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel